Novel approaches to combat chemoresistance against glioblastomas

The poor prognosis of glioblastoma multiforme (GBM) patients is in part due to resistance to current standard-of-care treatments including chemotherapy [predominantly temozolomide (TMZ; Temodar)], radiation therapy and an anti-angiogenic therapy [an antibody against the vascular endothelial growth f...

Descripción completa

Detalles Bibliográficos
Autores principales: Towner, Rheal A., Zalles, Michelle, Saunders, Debra, Smith, Nataliya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992560/
https://www.ncbi.nlm.nih.gov/pubmed/35582224
http://dx.doi.org/10.20517/cdr.2020.38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992560/
https://www.ncbi.nlm.nih.gov/pubmed/35582224
http://dx.doi.org/10.20517/cdr.2020.38

Ejemplares similares